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Summary 
We report here the first extensive study ofa T cell repertoire for a class I major histocompatibility 
complex (MHC)-restricted cytotoxic T  lymphocyte (CTL) response.  We have found that the 
T  cell  receptors  (TCRs)  carried  by  28  H-2Ka-restricted  CTL  clones  specific  for  a  single 
Plasmodium berghei  circumsporozoite nonapeptide are highly diverse in terms of Vg Jot, and JB 
segments and aminoacid composition of the junctional regions. However, despite this extensive 
diversity,  a high proportion of the TCRs contain the same V~8 segment. These results are in 
contrast to most previously reported T cell responses towards class II MHC-peptide complexes, 
where the TCR repertoires appeared to be much more limited. In our study, the finding of 
a dominant V/~ in the midst of otherwise highly diverse TCRs suggests the importance of the 
VB segment in shaping the T  cell repertoire specific for a given MHC-peptide complex. As 
an additional finding, we observed that nearly all clones have rearranged both TCR ot loci. Moreover, 
as many as one-third of the CTL clones that we analyzed  apparently display  two productive 
ot rearrangements. This argues against a regulated model of sequential recombination at the ot 
locus and consequently raises the question of whether allelic exclusion of the TCR ot chain is 
achieved at all. 
T 
he mouse TCR ot/~ is a disulphide-linked heterodimeric 
integral membrane glycoprotein. Each chain of •40- 
45 kD contains a C and a V extracellular  domain (1). The 
diversity of each ot and B V domain results from the somatic 
recombination of ",,100 Va with "~50 joining ot (Jot) gene 
segments and of '~20 V/5 with two diversity fl (DE) and 
12joining B (J~0) gene segments, respectively.  Imprecise  joining 
and addition of template-independent N-nucleotides further 
contribute to this diversity (2). The TCR is closely related 
to Ig by similar domain organization, overall sequence ho- 
mology, and conservation of key residues.  Along this line, 
Chothia et al. (3) have proposed an outline of the TCR ter- 
tiary structure, based on the known three-dimensional struc- 
ture of Igs. 
Whereas B cells recognize epitopes on native antigenic pro- 
teins, T cells can only recognize antigens in the context of 
cell surface syngeneic MHC molecules (4). The antigens rec- 
ognized by T  cells can be mimicked by synthetic peptides 
(5). The crystallographic structure of two class I MHC mol- 
ecules has revealed a groove in the external domain, where 
the antigenic peptide could lie (6-8). There is now evidence 
that the antigens are naturally processed into short peptides 
that are loaded onto MHC molecules and exported at the 
cell surface (9-11). 
The T cell specificity for an MHC-peptide complex is de- 
termined exclusively by the TCR (12). Accordingly, one ques- 
tion has received much attention. What is the diversity of 
the TCR.s carried by T  cells of a given specificity? 
The determination of the primary structure of a number 
of TCKs carried by T cell clones or hybridomas of a given 
specificity, mostly MHC class II restricted, has been performed 
for a variety of protein antigens, either of eucaryotic origin, 
such as pigeon cytochrome c (pcc)  1 (13-19), beef insulin (Bi) 
1  Abbreviations used in this paper: Bi, beef insulin; CS, circumsporozoite; 
HA, hemagglutinin; HEL, hen egg lysozyme; LCMVgp, lymphochorio- 
meningitis virus glycoprotein; MBP, myelin basic protein; pcc, pigeon 
cytochrome c; SpWMb, sperm whale myoglobin. 
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globin (SpWMb) (23), and murine myelin basic protein (MBP) 
(24, 25), or of viral origin, such as X repressor cI (~,cI) (26, 
27),  influenza virus  hemagglutinin (HA)  (28),  and lym- 
phochoriomeningitis virus glycoprotein (LCMVgp) (29, 30). 
Studies on hapten-specific  T  cells, for which the presented 
form of antigen is  unknown,  have been  also  undertaken 
(31-34). 
The general picture that emerges from these studies is that 
T cells of a given class II MHC-peptide complex specificity 
bear TCRs that exhibit a limited diversity.  This limitation 
concerns in most cases both ol and/3 chains,  and for each 
chain, both the V and J segments, and the amino acid com- 
position of the junctional region, where for the/3 chain a 
conserved amino acid was observed.  Strikingly, the selective 
pressure  is such that T  cells with identical TCR o~ and/or 
chains have been isolated from different individual mice 
at a high frequency. 
We  have  previously  reported  the  isolation  of H-2K  d- 
restricted CD8 + CTL clones specific for the P. berghei cir- 
cumsporozoite (CS) protein. (35, 36; Romero et al., manu- 
script in preparation).  Notably, some of these clones were 
shown to protect the mice from malaria upon adoptive transfer. 
In this system, the nonapeptide PbCS 252-260  was shown 
to be the most potent peptide both in terms of K d binding 
and CTL recognition (37). 
We have now determined the primary structure of the cr 
TCRs  carried  by  28  independent  H-2Ka-restricted  CTL 
clones specific for the P. berghei  CS nonapeptide using cDNA- 
PCR followed by sequencing. To this end, we have devel- 
oped and followed two original procedures.  First, we have 
screened each T  cell clone by PCR with a collection of 19 
Vol and 20 V~/oligonucleotides in conjunction with a Ca 
and a C~ oligonucleotide, respectively.  Second, we have set 
up new conditions for directly sequencing double-stranded 
PCR products (38). 
In this first extensive analysis of a class I MHC-restricted 
response, we found that although the TCRs were highly di- 
verse in terms of Vo4 Jc~, and J~/segments and amino acid 
composition of the junctional regions, the response was para- 
doxically dominated by a VB segment. We also observed that 
nearly all clones had rearranged both TCR ot loci and that 
in as many as one third of these clones, both rearrangements 
were apparently productive. 
Materials and Methods 
Cells.  The isolation of CTL clones CS.B28, CS.B83, CS.C1, 
CS.C7, and CS.Cll from BALB/c  mice immunized with P. berghei 
sporozoites has been described  dsewhere (35). The other CTL clones 
analyzed  in the present report were derived from mice immunized 
with synthetic P. berghei  CS peptides. CTL clones that were origi- 
nated from the same mouse are designated by a common capital 
letter followed  by a number for each done. The panel of 28 inde- 
pendent CTL clones was obtained from a total of 13 immune mice. 
Briefly, the CTL dones can be grouped into six categories based 
upon the strain of mice, the antigen used for in vivo priming, and 
the antigen used for in vitro stimulation as foUows: (a) BALB/c 
mice immunized by intravenous injection of irradiated P. berghei 
sporozoites and their spleen cells stimulated in vitro with the PbCS 
249-260 12-mer peptide (CTL B and C; total of five clones); (b) 
BALB/c mice immunized subcutaneously with the 10-mer PbCS 
251-260 coupled to a helper epitope and their lymph node cells 
stimulated  in vitro with the 10-met  peptide (Widmann et al., manu- 
script in preparation; CTL P, Q, and R; total of six clones); (c) 
(I~LB/c  x  C57BL/6)F1 mice immunized subcutaneously with 
the 12-met PbCS 249-260 and their lymph node cells stimulated 
in vitro with the same peptide (CTL E, F, and M; total of seven 
clones); (d) (BALB/c x  C57BL/6)F1 mice immunized intrave- 
nously with a lipid derivative  of the 9-met PbCS 252-260 and their 
spleen cells  stimulated  in vitro with the 12-mer PbCS 249-260 (CTL 
H and L; total of four clones). (e) BALB/c mice immunized intra- 
venously with the above lipopeptide and their spleen cells stimu- 
lated in vitro with the 12-mer PbCS 249-260 (CTL K; one clone). 
(f)  (BALB/c  x  C57BL/6)F1 mice immunized  subcutaneously 
with the 8-met PbCS 253-260 and their lymph node cells stimu- 
lated in vitro with the same peptide (CTL I and J; total of five 
clones). The details of in vivo priming and in vitro stimulation 
and cloning are reported elsewhere (35, and Romero et al., manu- 
script in preparation). Cloned cells were harvested 5-7 d after the 
last restimulation for cell surface staining or for RNA extraction. 
Cell Surface Labeling with VB-specific mAbs.  CTL clones were 
stained with several anti-V~ mAbs: F23.1 (anti-VB8.1, 8.2, 8.3), 
F23.2 (anti-V~8.2) (39), KJ16 (anti-VB8.1, 8.2) (40), 44-22-1 (anti- 
V~6) (41), Mm VB-TCR-6B (anti-VB13) (PharMingen, San Diego, 
CA),  14-2 (anti-V/~14) (42) and TR310 (anti-VB7) (43). Briefly, 
cells were stained with saturating amounts of the anti-V~ mAb 
followed by an appropriate FITC-labeled anti-Ig second reagent 
or Avidin-PE. Samples were passed on a FACS II  |  flow cytometer 
(Becton Dickinson & Co., Sunnyvale, CA). 
RNA Extraction, cDNA Synthesis, and PCR.  Total  RNA was 
extracted from 106 cells by disruption of the cells in guanidium 
thiocyanate  followed  by ultracentrifugation through a cesium  chlo- 
ride cushion. Pelleted tLNA was thereafter extracted once with 
phenol-chloroform, ethanol precipitated, and suspended in 50/~1 
water. Single-stranded cDNA synthesis was carried out on 5/~g 
total  RNA  with  oligo(dT)15 and  AMV  reverse transcriptase 
(Boehringer Mannheim Biochemicals,  Indianapolis,  IN) according 
to manufacturer's instructions. After an ethanol precipitation, the 
cDNA was suspended in 100/~1 water. PCR was carried out in 
100/~1 on 1/100 of the cDNA with 1.5 U ofTaq polymerase  (Cetus 
Corp., Emeryville, CA) according to manufacturer's instructions. 
The primers are listed in Table 1. 30 cycles, each of 95~  for 1 
min, 55~  for 1 min, and 72~  for 1 rain, were completed in a 
thermostater (Cetus Corp.). 
Direct Sequencing of Double-stranded Linear DNA.  The PCR 
products were ethanol precipitated and separated by electropho- 
resis on a 2% agarose gel. The band of interest was cut out, sub- 
mitted to electrodution, and the duted DNA ethanol precipitated. 
This double-stranded  linear DNA was directly sequenced  with the 
Sequenase version 2.0 kit (United States Biochemicals, Cleveland, 
OH) and 3SSdATP as described (38). Briefly,  0.4 pmol of template 
was boiled for 10 rain in 10 #1 with a 20-fold molar excess of se- 
quencing primer. The sample was rapidly transferred to a dry-ice 
ethanol bath. Labeling mix (5.5/~1) was added to the frozen pellet 
and the tube allowed to warm. Once the ice melted, the solution 
was incubated for ~30 s at room temperature and then four 3.5-#1 
samples were transferred to the borders of wells containings 2.5 
/~1 of the respective  ddNTPs mixtures. The 96-well plaque was then 
spun down and incubated at 37~  for 2 rain. The reaction was 
stopped by 5 ~1 of  stop solution. The sequence products were sepa- 
rated on an 8 M urea, 6%  acrylamide gel. 
Probabilities.  Let us consider that a rearrangement has a proba- 
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germline V, (D), and J pseudogenes and the frequency of unproduc- 
tive V(D)J recombinations. Let us also consider a probability p2 
for a productive rearrangement to shut off the recombination of 
the other locus: p2 depends on hypothetical post translational re- 
quirements, e.g., level of expression, heterodimer formation, cell 
surface expression, positive selection,  etc.  In any case, if the two 
ol loci rearrange sequentially and if the recombination is regulated, 
the proportion of cells with one productive plus one unrearranged 
(o~ §  two productive (ol §  §  and one productive plus one 
unproductive (~ §  c~ recombinations would be: 1/(2  -  pip2), 
(1  -  p2)p1/(2  -  lOipa), and  (1  -  p1)/(2  -  pip2),  respectively. 
Thus, since F~ must be a value between 0 and 1/3, and ira between 
0 and 1, these proportions can be estimated to be between 1/2 and 
3/5, 1/6 and 0, and 1/3 and 2/5, respectively. Our observed values 
for any of the three categories differ significantly from these ex- 
pected values. Even if we cannot rigorously discriminate between 
productive and unproductive rearrangements because  we do not 
have the full-length sequences,  it is established  that only 4 of 28 
CTL clones, at most, have still one unrearranged ol locus, instead 
of 14-17 as expected. Consequently, a regulated model of sequen- 
tial recombination is unlikely to hold at the TCK a  loci. 
Results 
A  collection  of 47  CTL  clones,  H-2K  d restricted  and 
specific for the PbCS nonapeptide 252-260, was derived from 
13 mice and is described elsewhere (35, 36; Romero et al., 
manuscript in preparation). The combination of different mice 
and VB cell surface expression, as determined by fluorescence 
staining (see Materials and Methods), indicated that at least 
23 clones were independent. All CTL clones were then tested 
by cDNA-PCR with a sense oligonucleotide specific for the 
Vfl determined by FACS  |  analysis and an antisense CB oli- 
gonucleotide (Table 1), followed by direct sequencing of the 
Table  1.  Oligonucleotides 
VB*  Sequence  (5' to 3')  Vow*  Sequence  (5' to 3') 
VB1 
v82 
v83 
V84 
VBS.1 
v~5.2 
vB6 
v~7 
v~8.1 
v~8.2 
vts8.3 
vB9 
v~10 
v~11 
VB12 
VB13 
VB14 
v~15 
vB16 
v~18 
cBs 
CCCAGTCGTTTTATACCTGAATGC  Val 
TCACTGATACGGAGCTGAGGC  V~2 
CCTTGCAGCCTAGAAATTCAGTCC  Va3 
GCCTCAAGTCGCTTCCAACCTC  V~4 
GTCCAACAGTTTGATGACTATCAC  V~5 
AAGGTGGAGAGAGACAAAGGATTC  V~6 
CTCTCACTGTGACATCTGCC  V~7 
TACAGGGTCTCACGGAAGAAGC  V~8 
CATTCTGGAGTTGGCTTCCC  V~9 
CCTCATTCTGGAGTTGGCTACCC  V~10 
ACGCAAGAAGACTTCTTCCTCCTGC  V~11 
TCTCTCTACATTGGCTCTGCAGGC  V~12 
ATCAAGTCTGTAGAGCCGGAGGAC  V~13 
GCACTCAACTCTGAAGATCCAGAGC  V~13.1 
GAAGATGGTGGGGCTTTCAAGGATC  V~34S-281 
AGGCCTAAAGGAACTAACTCCAC  V~A10 
ACGACCAATTCATCCTAAGCAC  V~BWB 
CCCATCAGTCATCCCAACTTATCC  V~BMA 
CACTCTGAAAATCCAACCCAC  V~BMB 
CAGCCGGCCAAACCTAACATTCTC  V~5T 
C~fJ  Sequence (5' to 3') 
GCACTGATGTCCATCTTCTC 
AAAGGGAGAAAAAGCTCTCC 
AAGTACTATTCCGGAGACCC 
CAGTATCCCGGAGAAGGTC 
CAAGAAAGACAAACGACTCTC 
ATGGCTTTCCTGGCTATTGCC 
TCTGTAGTCTTCCAGAAATC 
CAACAAGAGGACCGAGCACC 
TAGTGACTGTGGTGGATGTC 
AACGTCGCAGCTCTTTGCAC 
CCCTGCACATCAGGGATGCC 
TCTGTTTATCTCTGCTGACC 
ND 
ACCTGGAGAGAATCCTAAGC 
TCCTGGTTGACCAAAAAGAC 
TGGTTTGAAGGACAGTGGGC 
CATTCGCTCAAATGTGAACAG 
CAAATGAGAGAGAGAAGCGC 
GGAAAATGCAACAGTGGGTC 
GACATGACTGGCTTCCTGAAGGCCTTGC 
Sequence  (5' to 3') 
CBa  CCAGAAGGTAGCAGAGACCC  C~a 
CBb  CTTGGGTGGAGTCACATTTCTC  Cab 
TGGCGTTGGTCTCTTTGAAG 
ACACAGCAGGTTCTGGGTTC 
* V~ primers are sense oligonucleotides  designed according to each VB gene segment. The VB gene segment nomenclature follows that of references 
51, 67, 68, and 69. 
*  V~ primers are consensus sense oligonucleotides  designed according to the known members of each Vol subfamily. The Voe gene subfamily nomen- 
clature follows that of references 2, 45, 75, and 76. Nucleotide sequence of the V~13 subfamily (2) was not available. The Voe5T gene segment 
sequence and specific primer were kindly provided by P. Marche (Institut Pasteur, Paris, France). 
SThe Cfl primers are consensus antisense oligonucleotides for the CB1 and C/~2 genes (71, 72). C3b is located 3' to Cfla. 
II The Cc~ primers are antisense oligonucleotides designed according to the single Co~ gene (77, 83). Coeb is located 3' to Cola. 
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CTL clone  v~ 
B28  v67 
M1  Vpl4 
RAI0.3.3  V~I4 
B83  V66 
CII  V~6 
V~IO 
FI2  v~6 
V~I2  * 
Cl  vpS.l 
H3  Vp8.1 
Fl  Vp$.1 
V~5.2 
QAII.3.2  V~8.1 
17  Vp~.2 
F8  v68.2 
vp6 
E2~  V613 
QB7.3.2  Vpl3 
H2  V~13 
K1  V~13 
El5  V613 
PF2.10.1  V~13 
HI  V613 
J3  V~I3 
J5  Vpl3 
M2  V~13 
J2  V~13 
L4  V~I3 
PE5.1.1  V~13 
J4  Vpl3 
C7  v613 
RF3. i0.3  V613 
B 
CTL  clone  v~ 
B28  V~8.F3.3 
Ve4.~gR  * 
M1  V@8.F3.3 
Vu5.TA72 
~I0.3.3  V~8.F3.3 
V~5.MS202  * 
B83  V~8.F3.4 
V~I.B83  * 
CII  V~8.F3.5 
FI2  V~8.F3.3 
V~ST.J3  * 
C1  V~4~  * 
H3  V~I0.TA57 
V~BMA~ 
F1  V~7.S284EKp 
V~2~  * 
QAII.3.2  V~4.AII32 
V~8.F3.4  * 
[7  V~5.MI)A 
V~4.AII32 
F8  V~6.TAI 
V~I.II.3 
E22  VeS.F3.4 
V~4.~TR 
QB7.3.2  V~4.3 
V@8.F3.2 
H2  V~2.TAI9 
V~7.~ 
K1  V~3.~HD$58 
Ve4.3 
F]5  Va3.810 
V~BMB.42HII* 
PF2.10.1  V~3.AR5 
V~4.F2101 
HI  Vu~.3 
ve4.3  * 
33  VUST.J3 
V~I0.1F8  * 
J5  V~4.3 
M2  V~BMA.M2 
V~4.MDI3 
J2  v~2.Ra9 
L4  V@4.3 
PE5.I.I  v~2.81 
V@B.F3.3 
J4  VeBMAoPI4 
V~I.EI 
C7  V~3.pHDS58 
V~8.F3.3  * 
RF3.10.3  V~4.F3103 
Ve3.pHDS58  * 
...TGT  GCT  AGC  AGT  TCC  CGC  TAT  GAA CAG 
...TOT  GCC  TGG  eGG  ACT  GGC  GGG  TTT  GCT 
...TGT  GCC  TGG  AGC  AAG  GGG  GCG  ~GA  GGT 
,..TGT  GCC  AGC  ACC  CCC  ACC  GGG  AUA  AAC 
...TGT  GCC  AGC  ATC  CCG  ACG  GCA  AAC  ACC 
...TGT  GCC  AGC  AGG  CTA  TGA  ACA  GTA CTT 
...TGT  GCC  AGC  ATC  ~n~  ICI  GGG  ~C  ACC 
~  GCC  AGC  AGT  TTT  GGC  ACA  ACA  ACC 
￿9  ..TGT  GCC  AGe  AGT  GTG  ACA  GGG  TCA  AAC 
...TGT  GCC  AGC  AGT  GAT  TCA  CAG  GGC  ACA 
...TGT  GCC  AGC  AGT  GAT  GAG  GGA  GTG  GGG 
..~  GCC  AGC  TCT  CTC  CGG  SAC  AGG  GG~ 
.o.TGT  GCC  AGC  AGS  CCG  GGA  CAA  CCC  TAT 
..~  GCC  AGC  GGT  GAT  GGA AAC  CAG  GCT 
...TGT  GCC  AGC  GGT  GCG  ACT  GGG  nGG  GCA 
,..TGT  GCC  AGC  AGT  CAC  TAG  GGG  AGG  CCA 
~  GCC  AGC  AGT  CCT  ACA  GGG  AAA  TCA 
...TGT  GCC  AGC  AGT  CCC  CCC  f2~_~TT  GCA 
...TGT  GCC  AGC  AGT  CCC  ACA  GGT  AGA  AAC 
...TGT  GCC  AGC  AGG  AGG  CAG  GGT  GGC  ACA 
...TGT  GCC  AGC  AGT  CCT  CCT  CAG  GGG  AAC 
...TGT  CCC  AGC  AGT  TTC  CGG  GGG  GGG  CAA 
...TGT  GCC  AGC  AGT  TCA  GCC  AGG  GGT  GAC 
￿9  ..TGT  GCC  AGC  AGG  ~AC  Ang  GGG  CGC  ACC 
,..TGT  GCC  AGC  AGT  TCC  CCA  C~G  nnA TCC 
.~  GCC  AGC  AGT  TTG  GGA  CAG  GGG  GCT 
,..TGT  GCC  AGC  AGT  TTC  CCG  GAC  AGG  GCT 
..,TGT  GCC  AGC  AGC  CGA  CTG  GGG  GCT  TCC 
..~  GCC  AGC  AGT  TTC  CAA  TAT  GAA  CAG 
...TGT  GCC  AGC  AGC  CGC  CGG  GAC  AGG  G~T 
...TGT  GCC  A~C  AGC  CAC  GGG  GAT  TCA  AAA 
...TGT  GCC  AGC  AGT  CCG  GGA  CAn  ~nC  CTC 
...TGT  GCC  AGC  ~GC  CTA  CTG  GGG  ACC  AAG 
~  GCC  AGC  AGT  TCC  GCT  AGT  GCA GAA 
...TGT  GCT  CTG  AGT  GGA  GGT  TCA  GCC  TTA 
...TGT  GCT  CTG  GGT  GCC  CTG  GAG  GAA GCA 
...TGT  GCT  CTG  GGT  ACT  GGA  GGC  AAT  /&AT 
...TGC  GCA  GTC  AAT  ATG  GCT  ACT  GGA  GGC 
...TGT  GCT  CTG  AGT  GGG  TCG  AAT  CAA GGA 
...TGT  GCA  GTC  AGT  GTA  GTG  GAG  GCA  GCA 
...TGT  GCT  TTG  AAC  GGA  GGT  TCA GCC  TTA 
...TGT  GCA  GTG  AGG  TGA  GCT  CGG  GAT  ACA 
...TGT  GCT  CTG  AGT  GAA  ACA  GGA  GGT  GCA 
...TGT  GCT  CTG  AGT  GAT  CAA GGA  GGT  GCA 
...TGT  GCA  GCA  AGT  GAA  CAG  GAA  ACT  ACA 
...TGT  GCT  CTG  AGT  CTC  GTC  ATC  TTC  TGG 
...TGT  GCT  TTG  GGC  CTG  TTC  GGT  GAC  AAC 
~  GGC  ACT  GOA  GCT  AAC  ACT  GGA  AAG 
...TGC  GCT  CTC  TCG  GAT  CCG  TCT  AAT  TAC 
.~  GCA  GCA  AGT  GCC  GGA  ATA  ACA  ATA 
...TGT  GCT  CTG  GTG  AAT  TAC  AAC  GTG  CTT 
...TGT  GCT  TTG  AGT  CTA  CCA  GGG  AGG  CAG 
...TGC  GCA  GTC  AGT  GCC  TAT  GCA  AAC  AAG 
...TGT  GCT  CTG  CCA  ATA  ATA  ATG  CAG  GTG 
...TGT  ATC  CTG  AGA  GCG  GGT  TAC  CAG  AAC 
...TGT  GCA  GTT  TGA  ATC  AAG  GAG  GGT  CTG 
...TGT  GCT  TTG  GTA  AAT  TCT  GG~  ACT  TAC 
...TGT  GCT  CTG  AGT  GAC  GGG  GAA CAT  GGG 
...TGT  GCT  CTG  AGT  CAT  GGG  ACT  TAC  CAG 
...TGT  GCT  TTG  AGT  GGG  GAC  GAC  TCG  GGA 
...TGT  GCA  GCA  AGT  GCA  /&AT TCT  GGG  ACT 
...TGT  GCT  CTC  TGG  GAG  CTG  GCC  GGA  GGT 
...TGT  GCT  GTG  AGC  ATG  AAT  GAA  TAC  AGA 
...TGT  GCT  CTG  GGT  GAG  GGA  AGC  AAT  GCA 
...TGT  GCG  GGG  ACA  GGC  AAT  ACC  GGA  AAA 
...TGT  GCT  ATG  AGA  GAG  GGA  ATT  ATG  GGG 
...TGT  GCT  CTG  AGC  ATA  ACA GGC  AAT  ACT 
...TGT  GCT  CTG  GAC  CAG  ACA GGC  TTT  GCA 
..oTGT  GCC  CGC  GGC  ACC  AAT  ACA GGC  AAA 
...TGT  GTT  CTG  GGT  GGG  GGG  GAG  CAG  TGG 
...TGT  GCG  GGT  AAT  CAA  GGA  GGG  TCT  GCG 
...TGT  GCT  ATG  GTC  ACG  CGT  CCA  AGC  AGC 
o..TGT  CTC  TGG  GAA  CTG  GGA  ACT  GGG  TCT 
..~  GTC  TCA  AAT  TCT  GGG  ACT  TAC  CAG 
...CCA  AAT  A.%C TAT  GCC  CAG  GGA  TTA  CCA 
...TGT  GCA  GCG  GGC  ATA ACT  TTT  GGG... 
...TGT  GCT  CTG  GGT  GCC  CAG  GGA  GGC  AGA 
...TGT  GCA  GCA  AGA  GGA  GGA  AAC  TAC  AAA 
...TGT  GCT  CTG  AGT  GAT  CAA  GGA  GGT  GCA 
...TGT  GCT  GAC  AAT  AAC  AGA  ATC  TTC  TTT 
...TGT  GCA  GCT  AGT  GAG  CAA  TGG  GGG  TGG 
...TGT  GCT  GCG  AGT  TAT  GGG  GGC  AGT  GGC 
...T~T  GCT  CTG  AGA  AGG  CAA  TAC  TAG  AAA 
...T~T  GCT  CTG  GGT  GAT  CGG  TAT  GGG  GGC 
...TCT  GCT  GTG  AGC  CAA  CAG  GCA  ATA  CTA 
TAC  TTC  GGT... 
GAG  CAG  TTC  TTC  DGA... 
CAA  AAC  ACC  TTG  TAC  TTT  GGT... 
AAC  CAG  GCT  CCG  CTT  TTT  GGA... 
GGG  CAG  CTC  TAC  TTT  GGT..o 
CGG  T... 
GGG  CAG  CTC  TAC  TTT  GGT... 
AGC  TCC  GCT  TTT  TGG  A.,. 
ACA  GAA  GTC  TTC  TTT  GGT... 
GAA  GTC  TTC  TTT  GGT... 
~AA  AAC  ACe  TTG  TAC  TTT  GGT... 
ACA  CCG  GGC  AGC  TCT  ACT  TTG  CT... 
GAA  CAG  TAC  TTC  GGT... 
CCG CTT  TTT  GGA... 
AAC  ACC  GGG  C~G  CTC  TAC  TTT  DGT... 
AGA  CAC  CCa  GTA  CTT  TGG  G... 
AAC  ACA  GAA  GTC  TTC  TTT  GGT... 
AAC  ACA  GAA  GTC  %TC  TTT  GGT... 
ACA  GAA  GTC  TTC  TTT  GGT... 
GAA  GTC  TTC  TTT  GGT... 
CAA  GAC  ACC  CAG  TAC  TTT  GGG... 
GAC  ACC  CAG  TAC  TTT  GGG... 
ACC  CAG  TAC  TTT  GGG... 
AAC  GAA  AGA  TTA TTT  TTC  GGT~ 
AAC  GAA  AGA  TTA  TTT  TTC  GGT... 
TTT  AAC  TAT  GCT  GAG  CAG  TTC  TTC  GGA... 
AAC  TAT  GCT  GAG  CAG  TTC  TTC  GGA... 
TAT  GAA  CAG  TAC  TTC  GCT... 
TAC  TTC  GGT... 
CAG  GCT  CCG  CTT  TTT  GGA... 
CAC  CTT  GTA  CTT  TGG  T... 
ACC  GGG  CAG  CTC  TAC  TTT  GGT,.. 
ACA CCC  AGT  ACT  TTG  GG... 
ACG  CTG  TAT  TTT  GGC.., 
GGG  AGG  CTG  CAT  TTT  GGA... 
ATG  CAA  AGC  TAA CTT  CGG  G... 
AAG  CTG  A~T  TTT  GGT... 
AAT  AAT  AAG  CTG  ACT  TTT  GGT... 
GGG  TCT  GCG  AAG  CTC  ATC  TTT  GGG... 
ATT  ACA  AAC  TGA  CAT  TTG  GG... 
GGG  AGG  CTG  CAT  TTT  GGA... 
ACA  AAC  TCA  CTT  TTG  GA... 
GAT  AGA  CTC  ACC  TTT  GGG... 
GAT  AGA  CTC  ACC  TTT  GGG... 
AAT  ACG  TCT  TTG  GA... 
CAG  CTG  GCA  ACT  CAT  CTT  TGG  A... 
AGT  AAG  CTG  ATT  TGG  GGC~ 
CTC  ACG TTT  GGA... 
AAC  GTG  CTT TAC  TTC  GGA... 
ACA GAA  TCT  TCT  TTG  GT... 
TAC  TTC  GGA,.. 
AGC  TCT  GAT  ATT  TGG  A... 
ATG  ATC  TTT  GGC... 
CCA AGC  TCA CAT  TCG  GA... 
TTC  TAT  TTT  GGG... 
CGA  AGC  TCA  TCT  TTG  GG... 
CAG  AGG  TTT  GGA... 
CTA CAA  ACT  TAC  TTC  GGG... 
AGG  TTT  GGA... 
TA~  AAC  AAA  CTC  ACT  TTT  GGA... 
TAC  CAG  AGG  TTT  GGA... 
TCA GAC  CTT  AGG  GAG  AGC  TGC  AAT  TTT  GGA... 
GGT  GCA  GAT  AGA CTC  ACC  TTT  GGG.,. 
AAG  CTA  ~CC  TTC  GGG.,. 
CTC  ATC  TTT  GGA... 
GCA GTG  GCA  ACA  AGC  TCA  TCT  TTG  GA... 
AGA  AAA CTC  ATC  TTT  GGG... 
AGT  GCG  CTG  ACA  TTT  GGA... 
TTA  ACC  TTT  GGG... 
CAA  CAA GCT  CAT  CTT  TGG  A... 
AAG  CTC  ATC  TTT  GGG... 
AAG  GCA  CTG  GGT  CTA  AGC  TGT  CAT  TTG  GGoo. 
AAG  CTG  TCA  TTT  GGG... 
AGG  TTT  GGA... 
TTC  GGT..~ 
GCT  CTG  ATA  TTT  GGA... 
CCT  ACG  TTT  GGG... 
GAT  AGA  CTC  ACC  TTT  GGG... 
GGC... 
ATA GCA  ACT  ATC  AGT  TGA  TCT  GGG  GC... 
AAC  AAG  CTC  ATC  TTT  GGA... 
ACT  CAT  CAA TGG  G... 
AGT  GGC  AAC  AAG  CTC  ATC  TTT  GGA... 
G~A  AAC  TCA TCT  TTG  GG... 
JP 
0p2.9 
￿9  ~p2.1 
Jp2.4 
apl.5 
Jpz.~ 
Jp2.7 
J61.5 
J~l .i 
J61 ,I 
062., 
opz.9 
J62.z 
J6)..l 
apl.1 
Jpl.l 
Jpl.i 
J62.5 
Jp2.5 
J62.5 
J61.4 
J61.4 
Jpz,1 
o6z .~ 
opz,7 
o6z.7 
O~1.5 
J62.4 
JpZ.z 
Jp2.5 
J62.3 
JU 
JULB2 
J{~B28 
J(%2B4 
JCt2B4 
J  (IT  A27 
3(X3DT 
Jg{LB2 
J~@732 
JUTA80 
JUTAS0 
JUTAI9 
JUTA28 
J(~BDFLI 
JUt5 
JUI4.~ 
J~MD-13 
JUl  '%.  4 
J~U%IO 
Jel7 
J(ZTA37 
JUTA65 
J({TA27 
J~TA39 
JUI4T 
J•TA39 
JUB732 
JUTA39 
JUH2 
Jg~TA80 
JUKI 
J(XTA57 
JUTTII 
J(XC7 
JC~pHP$58 
J~TA61 
J(~520K 
J~TA27 
J(XTAI 
JeTAI 
J(XTA39 
J(~112.2 
J~TA31 
J~tAI  0 
JCtT6 
JUT  A@ 0 
J(IMDI 3 
J(~i-27 
J~TTII 
J(~C7 
J~TTII 
Jt~C7 
Fi~rm 1.  TCK a  and ~  cDNA 
junctional nur.leotide sequences. (A) 
TCR ~ eDNA junctional sequences. 
Out-of-frame  sequences  are  indi- 
cated by an asterisk. Nomenclature 
for V/3 gene segments follows that 
of references 67-69 and 51. Sequences 
are  in  references  67  (VBI,  VB6, 
v~7), 70 (vm0, vr  vm3), 68 
(VB14,  V~16),  and  51  (V~5.2, 
VB8.1, V/38.2). The J~ sequences 
are from references 71 and 72. The 
V~ and J~ gene segment sequences 
are identical  to the published  ones. 
However, two JB genes differ from 
the original reports: there is a base 
insertion (underlined) in  the JB1.5 
segment  (...  AACCA  _GGCT- 
CCG...)  and a base substitution 
(underlined) in  the J~1.4  segment 
(... CTGTCTGTCCTG...).  Each 
of  these changes occurred in  all 
respective CTL clones. The DE seg- 
ments are underlined  (73, 74). The 
CB1 and CB2 genes could not be 
discriminated  on a sequence  basis 
and probably follow the J~ cluster 
to which the VB is rearranged (71, 
72). (B) TCR. o~ cDNA junctional 
sequences.  Out-of-frame sequences 
are indicated by an asterisk. Nomen- 
clature for the Vol gene subfamilies 
follows that of references 2, 45, 75, 
and 76. The Vol subfamily is sepa- 
rated from the Vo~ gene segment by 
a period. The V~ gene segments are 
named  according  to  the  original 
cell in which  they were isolated, 
from references 77 (3.pHDS58), 45 
(5.TA72,  10.TA57, 6.TA1, 2.TA19), 
78  (5.MDA,  4.MD13,  1.E1),  14 
(4.3),  46  (8.F3.2,  8.F3.3,  8.F3.4, 
8F3.5),  79 (7.~2B4Exp),  33 (3.810), 
21  (BMB.42H11),  26  (2.81),  80 
(BMA.P14),  81 (4.(~7R),  24 (4.PJ- 
R25),  75  (7.2),  34  (3.AR5),  17 
(10.1F8), 82 (2.Ra9), 60 (5.MS202), 
23 (1.11.3),  and this report (1.B83, 
5T.J3,  BMA.H3,  2.F1,  4.Al132, 
4.F2101,  BMA.M2, 4.F3103). The 
Jo~ gene segments are from refer- 
ences  83  (TTll),  77  (pHDS58), 
78  (LB2,  MD13,  2B4,  C5),  45 
(TA27, TA80, TA19, TA28, TA37, 
TA65,  TA39,  TA57,  TA61,  TA1, 
TA31),  84  (BDFLI),  14  (14.4), 
32 (112.2),  33 (520K),  75  (3DT), 
59  (A10),  85  (14T),  86  (T6),  28 
(1-27),  and this report (B28, B732, 
I7, H2, K1, C7). The Voc and Jo~ 
gene segment sequences are identical 
to  the  published  ones.  However, 
Jo~MD13  in  clone J-4  differs  by 
a  silent  base  substitution  (under- 
lined) from the original Jo~MD13 
(...  TTTGC~  .  .  .).  These se- 
quences are available from EMBL/ 
C-enBank/DDBJ  under  accession 
numbers X60837  to X60921. 
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determination of putative sister clones,  i.e., CTL clones iso- 
lated from the same mouse and displaying an identical TCR 
[3 gene sequence.  Thus, 28 independent CTL clones could 
be identified unambiguously (Fig. 1 A). All studies described 
below were carried out on these 28 clones. 
Few CTL Clones Express Two Distinct VDJC [3 Transcripts. 
For  each  done,  the nudeotidic  sequence  of the amplified 
cDNA revealed an open reading frame encoding TCR [3 chain 
key residues (Fig. 1 A and Fig. 2). To further document these 
findings, we performed cDNA PCR on each CTL done with 
a coUection  of 20 digonudeotides  specific for each of the 
known functional V[3 gene segments of the V[3  b haplotype 
(Table 1). All these primers were shown to amplify the respec- 
tive V[3 gene segment under the experimental conditions used. 
6 of 28 CTL dones were found to express two different VDJC 
[3 transcripts. However, only one transcript was productive 
in every case (Fig.  1 A  and Table 2). Since most if not all 
V[3 gene segments are known (44), the combination of cell 
surface stainings and nudeotide sequences indicated that the 
transcripts encoding the functional [3 chains were unambig- 
uously determined (Fig.  2). 
Nearly All CTL Clones Express Two Distinct VJC et Tran- 
scripts.  We analyzed the VJC ot transcripts by cDNA-PCR 
followed by direct sequencing. Each CTL clone was tested 
separately with 19 consensus oligonudeotides designed ac- 
cording to the known members of 19 Vot subfamilies in con- 
junction with a Cot oligonudeotide (Table 1).  In contrast 
to the ;~ transcripts, 23 of 28 CTL clones were found to ex- 
press two different VJC ol transcripts (Fig.  1 B). One of the 
five CTL clones in which only one VJC ot transcript was 
detected,  C1, contained an out-of-frame transcript, and thus 
presumably expressed a second undetected in-frame transcript. 
Another CTL done, J5, was found to express an out-of-frame 
VDJC ~ transcript (Casanova et al., manuscript in prepara- 
tion). The remaining three clones, Cll, J2, and L4, could 
possibly retain one unrearranged ol locus.  However, given 
the large estimated  number of Vot gene segments and pos- 
CTL  clone  V~  FW  CDR3  FW  J~ 
B28  7  CAS  S  S  R  Y  E  Q 
M1  14  CAW  G  T  G  G  F  A  E 
RAI0.3.3  14  CAW  S  K  G  A  R  G  Q 
B83  6  CAS  T  P  T  G  T  N  N 
CII  6  CAS  I  P  T  A  N  T  G 
FI2  6  CAS  I  G  T  G  G  T  G 
C1  8.1  CAS  S  V  T  G  S  N  T 
H3  8.1  CAS  S  D  S  Q  G  T  E 
F1  8.1  CAS  S  D  E  G  V  G  E 
QAII.3.2  8.1  CAS  R  P  G  Q  P  Y  E 
I7  8.2  CAS  G  D  G  N  Q  A  P 
F8  8.2  CAS  G  G  T  G  G  A  N 
E22  13  CAS  S  P  T  G  K  S  N 
QB7.3.2  13  CAS  S  P  P  Q  V  A  N 
H2  13  CAS  S  P  T  G  R  N  T 
K1  13  CAS  R  R  Q  G  G  T  E 
FI5  13  CAS  S  P  P  Q  G  N  Q 
PF2.10.1  13  CAS  S  F  R  G  G  Q  D 
HI  13  CAS  S  S  A  R  G  D  T 
J3  13  CAS  R  D  R  G  R  T  N 
J5  13  CAS  S  S  P  Q  G  S  N 
M2  13  CAS  S  L  G  Q  G  A  F 
J2  13  CAS  S  F  R  D  R  G  N 
L4  13  CAS  S  R  L  G  A  S  Y 
PE5.1.1  13  CAS  S  F  Q  Y  E  Q 
J4  13  CAS  S  R  R  D  R  D  Q 
C7  13  CAS  S  P  G  Q  G  L  T 
RF3.10.3  13  CAS  S  S  A  S  A  E  T 
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Figure  2.  TCR ~  chain junc- 
fi  tional  amino  acid  sequences.  28 
2  CTL clones are listed on the ver- 
tical axis. For each clone, the TCR 
1  /3  transcript  with both  an  open 
1  reading  frame  and  the  triplets 
coding for key residues at the VDJ 
1  junction (3) was considered  to en- 
1  code the functional TCR/3 chain. 
For  all  clones  (~cept  B28,  not 
5  stained  by  the  antiV#7  mAb), 
5  the FACS  |  stainings with anti-V~ 
mAbs were in strict agreement with 
5  the ~ transcript assignments. The 
￿9 4  deduced amino acid sequences  (in 
single-letter amino acid code) of the 
4  junctional, hypervariable and puta- 
1  tively  CDR3-1ike  regions,  ac- 
cording to Chothia et al.  (3), are 
1  represented.  The presumed Ig-like 
7  loop, designated  CDR.3 for conve- 
nience,  is putatively supported  by 
7  two  framework  branches  (FW). 
5  The Cys residue is at position 92 
in the ~3 chain. The V/3 and J/3 seg- 
2  ments are also reported (see Fig. 1 
￿9  3  for references). Table  2.  Status of the TCR ot and fl V(D)JC Transcripts 
CTL clones 
Status*  cx  fl 
+ / -  17*(61%)  6 (22%) 
+ / +  8 (29%)  0 
+/0  3S(10%)  22 (78%) 
* The symbols + and -  indicate  transcripts that exhibit or not, respec- 
tively, an open reading frame at the V(D)JC junction, and the symbol 
0 indicates the absence of transcript detected by cDNA PCR. 
*  Clones M2 (+ / + ) and J5 ( +/0) are included  in this category  because 
they  express either  a nonfunctional,  although  in-flame,  ot transcript, due 
to the absence of the triplet coding for the key Cys residue at position 
90, or a t5 transcript, respectively.  Clone C1 (0/- ) is also included  be- 
cause it bears an ot/B TCR on the cell surface  and must therefore  express 
a productive ot transcript in addition to the unproductive  one detected 
(see Fig. 3 A). 
SThe three clones Cll, J2, and L4 might express an additional  t~ tran- 
script that would not hybridize  to the PCR primers (see Fig. 3 B). 
sibly subfamilies of unknown sequences, these clones might 
rather express an ot transcript that did not hybridize to the 
oligonucleotides used. 
Among the 23 CTL clones that expressed two ot transcripts, 
nine expressed both ot transcripts in frame at the VJCjunc- 
tion. In one of them, M2, the triplet coding for the key Cys 
residue at position 90 was deleted (3). Because of partial se- 
quencing, we cannot rule out that a Vot pseudogene seg- 
ment could render one of the two ot transcripts unproduc- 
tive in a number of these clones.  However, the estimated 
frequency of Vot pseudogenes is low (45--47). The remaining 
14 CTL clones expressed one transcript in-frame and one out- 
of-flame (Table 2). Thus, for 16 CTL clones that expressed 
either a second unproductive ot transcript (including M2) or 
a ~ transcript (J5), the transcript encoding the functional ot 
chain could be assigned unambiguously (Fig. 3 and Table 3). 
The Vf113 Gene Segment-encoded Region Is Overrepresented. 
Six Vfl gene segments from five different subfamilies are rep- 
resented (Fig.  2).  V[313 is predominant, found in 16 CTL 
clones (57%). The frequency of V[313 clones is lower among 
those from mice immunized with irradiated P. berghei sporo- 
zoites (1/5). Among CTL clones from peptide-immunized 
animals,  the frequency of V[313 usage is 74% (15/23).  The 
V[313 frequency among CD8 + lymphocytes in these strains 
of mice is between 3% and 5% (data not shown). Further- 
more, the V[313 predominance is unlikely to be the result 
of an increased  representation  of V[313 among H-2Ka-re  - 
stricted T cells, since only one V[313 usage was found in the 
analysis  of 25  independent  H-2Kd-restricted  CTL  clones 
specific for other peptides (data not shown). 
The TCR [3 Chain Primary Structures Are Otherwise Highly 
Diverse.  All 28 TCR fl chains differed from each other, and 
apart from the V[313 usage, no other predominant structural 
features  were identified for the [3 chain repertoire.  Indeed, 
10 Jfl segments, out of 12 possible  genomic segments, are 
used among 28 CTL clones. Even among the 16 Vf113 CTL 
clones,  eight different Jfl segments are used. Likewise, no 
preferential  Jfl segment usage was observed for the other Vfl 
segments. Furthermore, the length of the CDR3 loop, defined 
according to Chothia et al. (3),  varies from 6 to 12 amino 
acids, without striking dominant intermediate values.  The 
CDR3 lengths are also highly variable among CTL clones 
that share a given Vfl segment and even among those that 
share a given V[3-Jfl pair. When all loops of a given length 
were compared for the amino acid composition at a given 
position, no conservation could be found. Even when posi- 
tions were assigned with respect  to the Cys 92 residue (3), 
loops with different lengths did not show any obvious amino 
acid conservation. Moreover, even loops of a given length 
and supported by a given Vfl or Jfl framework failed to show 
amino acid conservation in the non-V/~ or non-Jfl-encoded 
regions, respectively. 
The Functional TCR ot Chains Are Also Highly Diverse  The 
16 known functional TCR ot chains were found to differ from 
each other (Fig.  3).  No Vot subfamily predominance such 
as the VB 13 among Vfls was observed.  Overall, 8 different 
Vot  subfamilies,  13  different Vot  gene  segments,  and  13 
different  Jot segments were found among the 16 CTL clones. 
Table  3.  Gene  Segments Used by Unambiguous Functional 
TCR Heterodimers 
CTL clone*  Vfl*  Jfl  Vot  Jo~ 
B28  7  2.7  8.F3.3  LB2 
RA10.3.3  14  2.1  8.F3.3  TA27 
B83  6  1.5  8.F3.4  LB2 
F12  6  2.2  8.F3.3  TA80 
F1  8.1  2.4  7.t~2B4Exp  14.4 
QAll.3.2  8.1  2.7  4.Al132  14.4 
17  8.2  1.5  5.MDA  17 
F8  8.2  2.2  6.TA1  TA65 
F15  13  2.5  3.810  TA57 
H1  13  2.5  4.3  TA61 
J3  13  1.4  5T.J3  TA27 
J5  13  1.4  4.3  TA1 
M2  13  2.1  BMA.M2  TA39 
J4  13  1.5  BMA.P14  MD13 
C7  13  2.2  3.pHDS58  TTll 
RF3.10.3  13  2.3  4.F3103  TTll 
* For 16 CTL clones, the functional  ot chain, engaged  in heterodirneric 
formation  with the fl chain and specific  of the H-2Ka-PbCS252-260 com- 
bination, was unambiguously  determined. Indeed, 14 clones express a 
second, out-of-flame,  ot transcript. In addition, clone  J5 expresses a 
transcript, and one of the two in-flame  ot transcripts from  clone  M2 has 
deleted the triplet coding for the key Cys residue at position 90. 
*  Nomenclature and references for the VB, Jfl, Vot, and J~ gene seg- 
ments are in the legend to Fig. 1. 
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A 
B28  8.F3.3  CAL  S  G  G  S  A  L  G  R  L 
RAI0.3.3  8.F3.3  CAL  S  G  S  N  Q  G  G  S  A  K  L 
B83  8.F3.4  CAL  N  G  G  S  A  L  G  R  L 
FI2  8.F3.3  CAL  S  D  Q  G  G  A  D  R  L 
C1 
F1  7.82B4Exp  CAL  S  D  P  S  N  Y  N  V  L 
QAII.3.2  4.AI132  CAL  V  N  Y  N  V  L 
I7  5.MDA  CAV  S  A  Y  A  N  K  M 
F8  6.TAI  CIL  R  A  G  Y  Q  N  F 
FI5  3.810  CAG  T  G  N  T  G  K  L 
HI  4.3  CAR  G  T  N  T  G  K  L 
J3  5T.J3  CAG  N  Q  G  G  S  A  K  L 
J5  4.3  CLW  E  L  G  T  G  S  K  L 
M2  BMA.M-2  CVS  N  S  G  T  Y  Q 
J4  BMA.PI4  CAD  N  N  R  I 
C7  3.pHDS58  CAA  S  Y  G  G  S  G  N  K  L 
RF3.10.3  4.F3103  CAL  G  D  R  Y  G  G  S  G  N  K  L 
B 
CII  8.F3.5  CAL  S  E  T  G  G  A  D  R  L 
J2  2.Ra9  CAA  G  I 
L4  4.3  CAL  G  A  Q  G  G  R  A  L 
FW  Jot 
HFG  LB2 
IFG  TA27 
HFG  LB2 
TFG  TA80 
YFG  14.4 
YFG  14.4 
IFG  I7 
YFG  TA65 
IFG  TA57 
TFG  TA61 
IFG  TA27 
SFG  TAI 
RFG  TA39 
FFG  MDI3 
IFG  TTII 
IFG  TTII 
TFG  TA80 
TFG  TA31 
IFG  AI0 
C 
M1  8.F3.3  CAL  G  T  G  G  N  N  K  L  TFG  2B4 
5.TA72  CAV  N  M  A  T  G  G  N  N  K  L  TFG  2B4 
H3  10.TA57  CAL  G  L  L  G  D  N  S  K  L  IWG  BDFLI 
BMA.H3  CGT  G  A  N  T  G  K  L  TFG  C5 
E22  4.~7R  CAL  S  D  G  E  H  G  L  Q  T  YFG  14T 
8.F3.4  CAL  V  N  S  G  T  Y  Q  RFG  TA39 
QB7.3.2  4.3  CAL  S  H  G  T  Y  Q  RFG  TA39 
8.F3.2  CAL  S  G  D  D  S  G  Y  N  K  L  TFG  B732 
H2  2.TAI9  CAA  S  A  N  S  G  T  Y  Q  RFG  TA39 
7.2  CAL  W  E  L  A  G  G  S  D  L  R  E  S  C  NFG  H2 
K1  3.pHDS58  CAV  S  M  N  E  Y  R  G  A  D  R  L  TFG  TA80 
4.3  CAL  G  E  G  S  N  A  K  L  TFG  K1 
PF2.10.1  3.AR5  CAL  S  I  T  G  N  T  R  K  L  IFG  C7 
4.F2101  CAL  D  Q  T  G  F  A  S  A  L  TFG  pHDS58 
PE5.1.1  2.8I  CAA  R  G  G  N  Y  K  P  TFG  T6 
8.F3.3  CAL  S  D  Q  G  G  A  D  R  L  TFG  TA80 
Figure 3.  TCR ot chain junctional amino acid 
sequences. The 28 CTL clones are separated  in three 
groups, as in Table 2. Group A (17 clones) gathers 
14 clones for which the functional ot chain can be 
unambiguously assessed due to the presence of a 
second, out-of-flame, ot transcript. It also includes 
clone  J5, which expresses a 8 transcript, and clone 
M2, which expresses two in-flame ot transcripts, 
one of them being, however, nonfunctional since 
it has deleted the triplet coding for the conserved 
Cys residue at position 90. Clone C1, for which 
we could not detect a productive ot transcript, is 
also included. Group B (three clones) gathers dones 
for which only one ot transcript was detected and 
found to be productive. Thus, we can not a~rm 
that the corresponding ot chain is necessarily  func- 
tional. Group C (eight clones) gathers clones that 
express two ot transcripts in flame at the VJjunc- 
tion, both potentially encoding  a functional ol 
chain. For each group, the ot chain-deduced amino 
acid sequence (in the single-letter code)  of the 
CDR3-equivalent  loop, according to Chothia et 
al. (3), is reported with the Vot and Jot segments 
(for references see Fig. 1). The key Cys residue is 
at position  90 in the ot chain. 
The  CDR3  lengths  were  found  to  be  extremely  variable, 
ranging from 4 to 11 amino acids and without any particular 
distribution.  Moreover, no obvious amino acid conservation 
was found,  even when loops of a given length  and/or  sup- 
ported by a given Vot or JoL framework were compared. When 
all different possible ol chains from the CTL clones for which 
the functional  ot chain was  only putative were included  in 
the analysis,  the structural  diversity  was  further increased. 
Altogether, the TCR c~ chain primary structures were found 
to be highly  diverse. 
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Discussion 
We have analyzed the TCKs  from 28  independent  CTL 
clones specific for the PbCS nonapeptide 252-260  presented 
by  the  H-2K a  restriction  element.  The  sequences  of  the 
amplified TCK ol and 3  cDNAs were determined. From this 
analysis, two major observations were made. First, nearly all 
CTL clones have rearranged both TCK c~ loci, and as many 
as one third of these clones apparently display two produc- 
tive ot rearrangements.  Second,  although  all TCK ot and fl 
chains differ from each other and are highly diverse in terms of both Vc~ Jo~, JB segments and amino acid composition 
of the junctional regions, where no conserved amino acid 
was found, there is a strong dominance of the V~13 segment. 
Rearrangements of the VDJ B Gene Segments.  All CTL 
clones express only one productive VDJC 3  transcript and 
a few (22%) express an additional unproductive one (Table 
2). This study at the mRNA level by cDNA-PCR provides 
reasonably reliable information on genomic VDJ rearrange- 
ments. Similar proportions at the genomic level are described 
for the Ig H chain locus in B cells, where a regulated model 
of sequential recombination is believed to account for allelic 
exclusion (48-50). In this model, a complete VDJ rearrange- 
ment occurs first on one chromosome, and only if this is not 
productive can the other locus then rearrange. Such a model 
predicts that on the average 40-50% of  peripheral cells should 
contain two distinct VDJ rearrangements (see Materials and 
Methods). The somewhat lower level (22%) in the present 
study could be explained in part by rearrangements involving 
a V3 pseudogene of the V3  b haplotype (44,  51,  52),  for 
which we did not design specific oligonudeotides. Since most 
if not all TCR V3 gene segments are presumably described, 
rearrangements involving new V3 segments are very unlikely 
(44).  Surprisingly, two mouse T  cell clones harboring two 
productive ~ rearrangements have recently been reported (53, 
54).  The relatively large series analyzed here suggests that 
the frequency of such ceils is very low and that consequently 
they may have little biological significance.  Altogether, the 
TCR 3  gene VDJ rearrangements appear to be consistent 
with a regulated model of sequential recombination that main- 
tains a strict allelic exclusion for the TCR B chain. 
Rearrangements of the vj ol Gene Segments.  In contrast 
to our findings for the B transcripts, nearly all CTL clones 
analyzed express  two distinct oe VJC transcripts (Table 2). 
Few previous studies have analyzed the status of rearrange- 
ments at both oe loci in T cell clones, mainly because of the 
size of the Joe locus, which extends over a stretch of 60 kb 
and thereby makes the analysis by Southern blot difficult and 
sometimes ambiguous (55-58).  In one study, only 3 of 10 
T  cell clones were reported to be rearranged at both c~ loci 
(58). In contrast, Malissen and colleagues (55) reported that 
both ol loci were rearranged in eight of nine T cell clones. 
Our cDNA-PCR approach with an extensive series of Vol 
primers followed by sequencing has allowed us to demon- 
strate unambiguously that at least 24 of 28 clones have rear- 
ranged both o~ loci. Thus, it is likely that both TCR oe loci 
are generally rearranged in most peripheral ol/B T  cells. 
At least 8 of the 28 CTL clones (29%)  specific for the 
P. berghei CS nonapeptide appear to express two productive 
ol transcripts. In the literature, three T cell clones have been 
described that dearly bear two productive ol rearrangements 
(59-62), but in the absence of an extensive study to estimate 
the frequency of such cells, their biological relevance was un- 
clear. Our study now indicates that the occurrence ofT cells 
that express two productive e~ transcripts is probably rather 
frequent. Moreover, it raises the question of whether TCR 
o~ chain allelic exclusion (i.e., the presence of a single hetero- 
dimer at the cell surface) is actually achieved in such lym- 
phocytes. 
Altogether, these results on the TCR oe gene VJ rearrange- 
ments strongly suggest that the recombination events at the 
TCR ~ loci differ considerably from those at the Ig and TCR 
3  loci, and that a regulated model of sequential recombina- 
tion may not hold for the TCR o~ genes (see Materials and 
Methods). 
Diversity of the TCR ~ and 3 Chains.  Several  class II MHC- 
restricted helper T cell responses to well-defined peptides have 
been reported. For some antigens, the number of sequences 
is too low to give an idea of the actual repertoire. For those 
studies with a sufficient number of sequences, there is dearly 
the occurrence of not only a dominant V3 segment but also 
an associated dominant J3 segment, a common CDR3 length, 
and a conserved amino acid in the non-V3-, non-J3-encoded 
part of the CDR3 loop (Table 4). However, the diversity of 
the repertoire varies  slightly from case to case and the re- 
sponse to HA appears  to be the most diverse.  In addition, 
a very striking feature is the fact that T  cell clones bearing 
TCR/~ chains identical at the amino acid level could be iso- 
lated in all these studies from different individual mice at a 
high frequency. In contrast, apart from the V313 dominance, 
we found no structural limitations in the CTL response to 
the P. berghei CS nonapeptide-K  d complex and no identical 
chains, despite a larger number of clones analyzed. 
A  striking recurrence of particular combinations of Vo~ 
gene subfamily, Jot segment, and CDR3 length has been ob- 
served in most class II MHC-restricted T cell responses ana- 
lyzed (Table 5). Most strikingly, T cell clones bearing iden- 
tical ot chains were isolated from different individual mice. 
This is again compelling evidence for a very strong selective 
pressure, given the potential diversity of the receptor chains. 
As an exception, the response to HA appears to be more di- 
verse. However, the function of the proteins encoded by the 
ol transcripts in the latter study is only putative, since data 
on the second TCR ~ locus are lacking. In the present study, 
in which we analyzed not only many but, most importantly, 
unambiguously assigned functional oe chains, we found no 
dominant Vo~ usage, no limitations on the junctional struc- 
tures, and no identical oe chains. 
For the 16 CTL clones in our study where the functional 
oe/3 pairing is unambiguous (Table 3), there is no obvious 
preferential J~'JB pairing, nor Vow-V3 pairing. Rather, there 
is  a large diversity of pairing between chains encoded by 
different Vo~ and V3 gene subfamilies or segments. Thus there 
are 11 or 15 different or/3 pairs, considering V gene subfami- 
lies or segments, respectively, out of 16 TCRs. Notably, the 
V313 and V~8 subfamily-encoded chains appear to be mutu- 
ally exclusive with those of Voe8. If the remaining 12 clones 
are included in the analysis, the diversity of pairing is further 
increased. In contrast, most other T cell responses analyzed 
to date display limited pairing diversity. Of these, the HA 
response appears  to be the most diverse,  but again,  the o~ 
chains are only putative and so the pairing among functional 
chains could possibly be less diverse. In many studies, TCRs 
identical not only for one chain but for both the c~ and 
chains were isolated from different individual mice (Table 5). 
Each of the 28 CTL clones has a unique fine specificity 
pattern  when  tested  for  recognition  of a  series  of Ala- 
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MHC-peptide  Total  Identical  Dominant  Dominant  Dominant  Conserved 
complex*  Strain*  TCK/~s  TCR ~11  V~  (n)  J/$ (n)  length  (n)  amino acid** 
MHC class II 
pccsH04/IE  k  B10.A,  F~/A  15  2,2,2,2,2  V~3  (7)  J~1.2  (5)  9  (5)  N 
VB16 (6)  Jfl2.1  (6)  9 (6)  DT 
pccslq04/IE'  B10.S(9R),  Ft/9R  7  2  V~I  (6)  JB1.2  (5)  8 (3)  D 
SpWMb,~m/IE  d  DBA/2  6  3  V~8.2  (6)  JB2.7 (5)  10 (5)  WDW 
MBP~.9N^c/IA  ~  PL/J,  (P  x  S) Ft  8  2,2,2  VB8.2  (7)  J~2.7  (4)  8  (4)  GLG 
B10.PL  6  4  VB8.2 (5)  JA82.7  (5)  9 (5)  AGG 
Xcllz.26/IE  k  A/J  11  3,2  VB1  (8)  JB2.1  (7)  10 (7)  E 
HA~0~20/IE  d  BALB/c  13  3  V~8.3  (7)  JB1.3  (4)  8  (4)  G 
MHC class I 
PbCS2s2.260/K  d  BALB/c,  (B  x  C)F1  28  NF**  VB13 (16)  NF  NF  NF 
* For references, see Introduction.  Only studies with at least six sequenced TCRs specific for a given MHC-peptide complex are included. Thus, 
studies on HEL-, Bi-, pcc (B10S[SR])- and LCMV-specific T cells are not reported. Studies on hapten-specific T cells are not mentioned because 
the processed form of the antigen is unknown. 
*  Responses to a given MHC-peptide combination in different strains are considered separately, with the exceptions of chimeras (F1/A [(B10A x 
BIOS[9R])F~ bone marrow in B10.A irradiated host] and Ft/9R [(B10.A x  B10.S[9K])F1  bone marrow in irradiated B10.S(9R)], as well as hybrids 
(P  x  S)F1 ([PL.J  x  SJL]Fa)and (B  x  C)F1 ([BALB/c  x  C57BL/6]F1). 
S  Only sequenced TCR B chains are considered. The numbers indicate the total number of sequenced/S chains for each particular specificity and 
strain. Probable sister clones, i.e.,  clones displaying the same TCR gene sequence and coming from the same animal, are excluded. 
II Only identical TCR/S chains isolated from different individual mice are reported, irrespective of the V/~ or JB usage. Each number indicates how 
many chains share a given structure. For example 3,2 means that two distinct groups of identical chains were found, one with three members, and 
one with two members. 
￿82  Any element, gene segment (V~/, J/S) or CDR3 length (3), is said to be dominant if it represents more than a third of the previous dement(s), 
in the order of the Table. The nature of these elements in each case is given in the V/S, J/S, and length columns, respectively, n indicates the number 
of TCRs sharing this element among the ones carrying the previous one(s). 
** Conserved amino acid indicates the non-VB, non-J/s-encoded  conserved residue (single-letter code) in the CDR3 loop among TCRs sharing the 
previous dominant V/s-JB-length combination (only N in the pcc [B10.A] response  is not absolutely conserved, present in four out of five TCR/~ chains). 
** None found. 
Table  5.  Comparison  of the TCR cr Chain Repertoires Reported  for Various Antigens 
MHC-peptide*  Total  Identical  Identical  Dominant  Dominant  Dominant 
complex  Strain*  TCR oes  TCR oetl  TCRoe/3  Vce (n)  Jo~ (n)  length (n) 
MHC class II 
pccsl.104/IE  k 
SpWMb110-m/IE d 
MBP1.gNAo/IA" 
XcI12.2JIE  k 
HA,~120/IE  d 
MHC class I 
PbCS2s2.~0/K  d 
B10.A,  F1/A  16  4,2,2,2  2,2,2  Vcdl  (15)  Jo~TA84  (10)  9  (6) 
DBA/2  6  3  NF  Vc~l  (4)  Jc~C5 (3)  10 (3) 
PL/J,  (P  x  S)F1  8  3,2  2  Vc~4 (8)  Jc~TA31  (6)  9 (6) 
B10.PL  7  6  3  Vc~2 (6)  JccTA39 (6)  8 (6) 
A/J  11  3,3  3  Vot2 (11)  JotTA1  (7)  8  (6) 
BALB/c  13  NF  NF  NF  NF  NF 
BALB/c, (B  x  C)F1  16  NF  NF  NF  NF  NF 
For abbreviations and references, see Table 4. The Vot indicates subfamilies. As opposed to the 3 chain, the non-V, non-J-encoded region of the 
ot chain is too small and unprecise to look for amino acid conservation. 
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preparation).  The clones thus appear to recognize a large 
number of epitopes  on the CS  nonapeptide-K  d complex. 
This heterogeneity of fine specificity patterns clearly corre- 
lates with the diversity of TCR primary structure found for 
this set of CTL clones specific for the P. berghei CS nonapepfide- 
K d complex. 
A  Paradoxical VB Dominance.  As mentioned previously, 
the dominance of the V~13 gene segment may be peptide 
related, at least in part,  since other Kd-restricted responses 
apparently fail to show a V~13 dominance. In agreement, 
a similar V~ dominance has been reported for the other re- 
sponses studied, with no apparent correlation to the restric- 
tion element (Table 4).  In the currently prevailing models 
of TCR-MHC-peptide interaction (3, 63, 64), the CDR-1- 
like and CDR2-1ike loops of both c~ and B chains, encoded 
by the Vc~ and V~/gene segments, respectively, are thought 
to interact with MHC residues, whereas the CDR3-1ike loops 
would interact with the peptide. This general topology was 
based on the much higher variability of the CDR3 loop and 
the peptide, when compared to CDR1 and CDR2 loops and 
the MHC molecule, respectively. It is now supported by in- 
creasing experimental evidence, showing that naturally oc- 
curring (14, 16, 18, 23, 27, 28) and experimentally engineered 
(65) TCRs that vary only in a CDR3 loop display distinct 
peptide fine specificities. Accordingly, an apparently peptide- 
related VB dominance in the context of otherwise highly di- 
verse TCRs, such as we found in this study, is paradoxical. 
In the other studies, the overall diversity of the TCRs is very 
limited, thus, the V~ dominance might be considered as an 
indirect consequence of a peptide-related constraint acting 
on other parts of the receptor, for example on the conserved 
amino acid in the CDR3 loop thought to be a peptide con- 
tact residue (16, 27,  65).  In contrast, the high diversity of 
the TCRs in this study strongly suggests that the VB domi- 
nance in general might result from direct peptide-related con- 
straints imposed by the peptide-MHC complex. Whether 
the VB dominance reflects a direct interaction of the VB seg- 
ment with the peptide or an indirect effect of the bound pep- 
tide on the complex that in turn would favor the interaction 
of the VB segment with the restriction element is unknown. 
What Determines the Size of'the  TCR Repertoire?  Apart 
from the VB dominance, the extent of diversity of the T cell 
repertoire appears to vary considerably according to the MHC- 
peptide ligand involved. Why the CTL response to a P. ber- 
ghei nonapeptide appears to be more diverse than the other 
reported T cell responses is unknown. It may be significant 
that the latter studies analyzed class II MHC-restricted T helper 
responses.  This difference might allow a compensation for 
the apparently lower number of class I-than class II-restricted 
antigenic sites within proteins. 
More likely, the size of the MHC-peptide complex-specific 
repertoire would depend primarily on the overlap between 
epitopes displayed by self peptides and the antigenic peptide 
bound to the same restriction element. This would explain 
why the responses towards polymorphic variants of self pro- 
teins (pcc, SpWMb) are so limited and the autoimmune re- 
sponse against MBP is oligoclonal. Even the XcI peptide, al- 
though  of viral  origin,  has  been  shown  by  Gefter  and 
colleagues (66)  to be homologous to a self peptide able to 
bind the same restriction element. Conversely, responses to 
the viral HA determinant and the parasite CS peptide may 
be more diverse because relatively few self peptides would 
generate overlapping tolerogen epitopes. Although the CTL 
response to the whole P. berghei CS protein in H-2  a mice is 
focused primarily on a single nonapeptide in the context of 
H-2K  d, this peptide may be so distant to self that it triggers 
a highly diverse, and presumably highly potent, T cell response. 
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